发明名称 Targeted integration and expression on exogenous nucleic acid sequences
摘要 Disclosed herein are methods and compositions for targeted integration of a exogenous sequence into a predetermined target site in a genome for use, for example, in protein expression and gene inactivation.
申请公布号 US9260726(B2) 申请公布日期 2016.02.16
申请号 US201313787473 申请日期 2013.03.06
申请人 Sangamo BioSciences, Inc. 发明人 Gregory Philip D.;Holmes Michael C.;Rebar Edward J.;Urnov Fyodor
分类号 C12N15/90;C12N9/22;A61K48/00;C12N15/62 主分类号 C12N15/90
代理机构 Pasternak Patent Law 代理人 Pasternak Patent Law ;Abrahamson Susan
主权项 1. An in vitro method for expressing a product of an exogenous nucleic acid sequence in a mammalian cell, the method comprising: (a) expressing a first fusion protein in the cell, the first fusion protein comprising a first zinc finger binding domain and a first FokI cleavage half-domain, wherein the first zinc finger binding domain has been engineered to bind to a first target site in a region of interest in the genome of the cell, wherein the first cleavage half-domain comprises a mutation in the wild-type amino acid residue at position 486 to a Glu (E) residue and further wherein the region of interest is in an endogenous region of the genome that is transcriptionally active and not essential for viability; (b) expressing a second fusion protein in the cell, the second fusion protein comprising a second zinc finger binding domain and a second FokI cleavage half domain, wherein the second zinc finger binding domain binds to a second target site in the region of interest in the genome of the cell, wherein the second target site is different from the first target site, and further wherein the second cleavage domain comprises a mutation in the wild-type amino acid residue at position 490 to a Lys (K) residue; and (c) contacting the cell with a polynucleotide comprising the exogenous nucleic acid sequence and a first nucleotide sequence that is homologous to a first sequence in the region of interest; wherein binding of the first fusion protein to the first target site, and binding of the second fusion protein to the second target site, positions the cleavage half-domains such that the genome of the cell is cleaved in the region of interest, thereby resulting in integration of the exogenous sequence into the genome of the cell in the region of interest and expression of the product of the exogenous sequence.
地址 Richmond CA US